Founder & CEO @ ClinSource Global, Inc. is a life sciences outsourcing advisory services company, consulting firm & group purchasing organization (GPO) established in 2013 to assist sponsors, service providers & other stakeholders with every aspect of outsourcing from people, products & processes to systems, cost-savings & services. Very simply stated, our goal is to simplify the complexities of outsourcing & maximize the operational & strategic value of internal & external investments in outsourcing for our clients. Contact: +1 (617) 417-8787; ian.lauf@clinsourceglobal.com Projects Completed for Clients: - Risk-based Monitoring (RBM) Market Research, Intelligence & Analysis Report: clinical service provider was seeking an acquisition of RBM service provider or investment in internal infrastructure to capitalize on RBM trend (make vs. buy decision) - Sponsor-CRO Relationships & Alliances:The State of the Industry &Implications for CRO Business Development: major CRO requested presentation at annual global business development meeting to discuss sales & partnership industry trends with entire global sales & marketing team & recommend methods for increasing sales effectiveness with clinical outsourcing departments on sponsor side - Market Research, Intelligence & Analysis Report for Oncology CRO Market: major CRO was seeking an acquisition of Oncology CRO or investment in internal infrastructure to capitalize on Oncology clinical research trend (make vs. buy decision) - Global Strategic CRO Partnership: assisted major medical device company with establishing first global strategic CRO partnership in medical device industry; services included negotiating MSA, rate card, discounts, milestone performance incentives/penalties & many other business terms & conditions directly with CRO, establishing governance/oversight structure between medical device company & CRO, developing KPIs & associated incentives/penalties, & other strategic partnership documents/materials From December 2013 to Present (2 years 1 month) Council Member @ Key Achievements: - Provide pharmaceutical/biotechnology industry consulting services to the world’s leading mutual funds, hedge funds, private equity firms, management consultancies, law firms & corporations. From May 2015 to Present (8 months) Advisor @ Key Achievements: - Provide pharmaceutical/biotechnology industry consulting services to the world’s leading mutual funds, hedge funds, private equity firms, management consultancies, law firms & corporations. From November 2013 to Present (2 years 2 months) Executive Forum Member @ Key Achievements: - Provide pharmaceutical/biotechnology industry consulting services to the world’s leading mutual funds, hedge funds, private equity firms, management consultancies, law firms & corporations. From October 2010 to Present (5 years 3 months) Advisor @ Key Achievements: - Provide pharmaceutical/biotechnology industry consulting services to the world’s leading mutual funds, hedge funds, private equity firms, management consultancies, law firms & corporations. From September 2009 to Present (6 years 4 months) US Head, Global Clinical Outsourcing & Alliance Management @ - Manage 5 direct reports. - Responsible for $300 million USD of yearly global clinical outsourcing spend. - Hand-picked by president to be secretariat of global, company-wide, cross-subsidiary, cross-functional special confidential project. From November 2013 to February 2015 (1 year 4 months) Associate Director, Clinical Alliance Management @ From June 2013 to October 2013 (5 months) Global Sourcing Manager, Medical & Clinical Trial Central Services @ Key Achievements: - Focused on improving the value of global & regional external partnerships by minimizing complexity of sourcing strategies, consolidating & leveraging global & regional volume/spend & delivering enhanced quality & compliance, consistency of deliverables, ongoing continuous improvement & innovation, cost savings/cost avoidance & improved reliability of clinical vendor performance & sponsor inspection readiness via development & implementation of key performance indicators (KPIs), formal governance meetings & cross-functional steering committees, standard communication plans & roles/responsibilities charts, issue logs & issue escalation processes. From May 2011 to May 2013 (2 years 1 month) Senior Global Agreements Specialist @ Key Achievements: - Recruited & hired by ex-colleagues to rejoin former team & provide temporary leadership & subject matter expertise during integration of departments, tools, templates, policies & procedures necessitated by Merck/Schering-Plough reverse merger. From February 2011 to May 2011 (4 months) Outsourcing Manager @ Key Achievements: - Negotiated $4.4 million in cost savings & cost avoidance with Oncology clinical trial service providers. - Selected to manage Novartis’ Oncology Business Unit functional outsourcing service provider model for statistics & statistical programming functional areas with annual spend of $35 million. From February 2010 to September 2010 (8 months) Manager, Outsourcing Lead @ Key Achievements: - Selected to lead multidisciplinary, cross-functional team responsible for evaluating current & establishing new Oncology outsourcing strategies & initiatives to improve the quality of project deliverables, reduce timelines & increase efficiencies for Pfizer’s newly created Oncology Business Unit. - Presented Individual Performance Award for exceptional performance & leadership demonstrated on Pfizer’s Oncology Business Unit outsourcing strategies & initiatives project. - Assumed responsibility for negotiating highly complicated, politically sensitive Master Services Agreement with vendor providing critical Neurosciences services for clinical trials after two years of unsuccessful negotiations & communications by/from colleagues. From January 2008 to January 2010 (2 years 1 month) Senior Manager & Team Lead, Clinical Trial Costing & Contract Development @ Key Achievements: - Effectively assumed 50% of Associate Director, Clinical Trial Contracting’s leadership role & management responsibilities during Associate Director’s unexpected five month leave of absence in addition to successfully managing responsibilities & project deliverables in Senior Manager & Team Lead roles. - Nominated for & selected to participate in 2007/2008 International Management Development Program. - Received one Golden Achievements Program Champion Standing Ovation Award, nine Manager-to-Employee Awards & one Peer-to-Peer Award for superior customer service, leadership & teamwork skills & consistent high quality of project deliverables. - Initiated development of new clinical trial, confidentiality & coordinating investigator agreement templates & associated processes & procedures & led multidisciplinary, cross-functional team responsible for project deliverables. - Identified need for, developed & successfully implemented standard of care budget process for Oncology clinical trials which decreased company’s fiscal responsibilities & investigators’/clinical trial sites’ risks of filing false claims. From December 2005 to January 2008 (2 years 2 months) Finance & Contract Analyst @ Key Achievements: - Reduced 2005 operating budget by $5.7 million by developing, implementing & managing financial & contract tracking tools. - Awarded two MedImmune Director’s Awards for remarkable accomplishments & teamwork during March 2005 quarterly budget review. - Decreased average quarterly budget variance from 36% to < 5% by providing financial & contract education & training to Medical Affairs staff. - Identified $392,146 in recoverable funds via enforcement of contract terms & conditions. From December 2004 to December 2005 (1 year 1 month) Assistant/Associate Medical Program Financial Specialist @ Key Achievements: - Decreased clinical trial liabilities by $4.3 million through clinical trial budget negotiation process with investigators/clinical trial sites. - Reduced clinical development costs by 19% via completion of worldwide clinical development cost-effectiveness analyses. - Managed $49.2 million worldwide HIV vaccine clinical development strategic alliance with NIH & $4.1 million U.S. HIV vaccine clinical development joint venture with Aventis-Pasteur. - Promoted from Assistant to Associate Medical Program Financial Specialist after six months in position due to exemplary performance & measurable accomplishments. - Selected to participate in Merck Mentoring Program. From November 2002 to December 2004 (2 years 2 months) Assistant Data Management Coordinator @ Key Achievements: - Supported an FDA filing, Worldwide Clinical Summary & five manuscripts for Crixivan® (indinavir sulfate). - Appointed Protocol Lead for MK-639 protocol 060 (Crixivan®), Lead Data Reviewer for MK-869 protocol 060 (depression) & Data Review Trainer/Mentor for MK-869 clinical development program. - Presented Certificate of Appreciation for outstanding performance & important contribution to MK-869 protocol 060. From March 2001 to November 2002 (1 year 9 months) Medical Equipment Analyst @ Key Achievements: - Identified $279 million in potential diagnostic imaging equipment cost savings for U.S. clientele. - Assisted Banner Health with cost analyses for $19.6 million project to acquire 14 MRI units. - Completed capital equipment procurement projects for top ranked U.S. hospitals, medical schools & health care systems, including Mayo Clinic, Cleveland Clinic & Partners Healthcare. From July 2000 to March 2001 (9 months)

MBA, Pharmaceutical Business @ University of the Sciences in Philadelphia From 2002 to 2005 BS, Public Health @ Stockton University From 1996 to 2000 West Deptford High School From 1992 to 1996 Ian Lauf is skilled in: Vendor Management, Contract Management, Budgets, Contract Negotiation, Contractual Agreements, Negotiation, Outsourcing, Process Improvement, Strategy, Data Management, Protocol, CRO, Leadership, Oncology, Program Management